EDDC is excited to share that we will be collaborating with Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, to bring forward an innovative approach for early drug discovery and development. In this partnership, Partex will initially use its “Asset Exchange” technology platform to identify novel indications for EDDC’s portfolio assets. The parties intend to broaden this partnership to combine AI technology, scientific expertise and wet lab validations to accelerate the progress of new drug discovery programmes.

We look forward to working with Partex to accelerate the process of translating innovative scientific discoveries into great medicines.

Read the full press release here!